Skip to content
Search

Latest Stories

PSNC in talks with government on COVID-19 action plan for pharmacy

The Pharmaceutical Services Negotiating Committee (PSNC) said it has commenced discussions with the government regarding the recently published coronavirus action plan.

The organisation has discussed matters such as the provision of protective equipment for pharmacies, contingency funding for any pharmacies who need it, protection for pharmacies against sudden medicines price rises and ensuring the ongoing provision of pharmaceutical services in case of significant volumes of staff absences.


Much of these were build on previous discussions about the pandemic planning, PSNC stated in a statement.

Simon Dukes, PSNC Chief Executive, said: "The evolving COVID-19 situation is worrying for many people in the UK but particularly so for the health professionals on the front line. Community pharmacy teams are already putting themselves at risk dealing with this illness, and that will continue to be the case as this situation worsens. Pharmacies must be treated as a core part of the NHS in all epidemic planning, and PSNC will ensure that HM Government is aware of the critical part they have to play and the support – including financial – they will need through any epidemic."

Dukes said the government was in the “early stages of planning the response to COVID-19, building on the considerable pandemic planning work of the past.”

“There are many details still to be worked out and PSNC will be a part of those discussions, looking at how we can best protect the network of community pharmacies and allow them to continue their crucial work through this crisis. We will continue to update contractors as often as we can," he added.

NHS England and Improvement recently published an initial coronavirus guidance for community pharmacy. PSNC said the government’s latest action plan will be supported by further guidance to the NHS, including community pharmacies, in due course.

More For You

NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less
Many patients report inaccuracies or missing details in their NHS medical records

Inaccurate information can result in serious harm or even death, warns Healthwatch England.

Image Credit: Getty Images

1 in 4 adults have spotted errors in their NHS medical records, survey finds

Healthwatch England has raised the alarm over the risks posed by inaccurate medical records as research reveals widespread errors in NHS patient information.

Commissioned by Healthwatch England and conducted by BMG Research, the survey polled a representative sample of 1,800 adults in England between 24 and 27 March 2025.

Keep ReadingShow less
Pharmacies NHS weight loss jabs

Pharmacies already sell the medication as a private service

Pic credit: iStock

Pharmacies in line to roll out NHS weight loss jabs

Pharmacies are “best placed” to deliver a planned rollout off greater access to weight loss jabs which could benefit 3.4 million people in England.

Reports today claim the government is looking at trials that would see the medication made available following a short, over-the-counter consultation for the price of an NHS prescription.

Keep ReadingShow less
Numark welcomes hub and spoke change, but calls for clear economic model

The H Human Medicines Regulations amendments will come into force on 1 October 2025.

Image credit: Getty Images

Hub and spoke dispensing between separate pharmacy businesses to begin in October

Community Pharmacy England (CPE) has confirmed that the government has laid amendments to the Human Medicines Regulations 2012 (HMR) in Parliament, marking a crucial step towards enabling hub and spoke dispensing between separate community pharmacy businesses.

The Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025 are set to come into force on 1 October 2025.

Keep ReadingShow less
Lib Dems condemn rising unsolved crimes, say shoplifting and burglary ‘effectively decriminalised’

Leicestershire police recorded the lowest charge rate for shoplifting in the country.

Gettyimages

Shoplifting and burglary ‘effectively decriminalised’, warn Lib Dems as unsolved crimes soar

The Liberal Democrats have raised alarm over what they describe as the “decriminalisation” of burglary and shoplifting, as new data reveals that the vast majority of such offences across Britain are going unsolved.

Figures revealed by the House of Commons Library research, commissioned by the party, showed that only 5.25 per cent of shoplifting offences in London last year led to a suspect being charged.

Keep ReadingShow less